PHARMACOLOGY OF LOCAL ANESTHESIA

46,618 views 145 slides Mar 23, 2018
Slide 1
Slide 1 of 145
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67
Slide 68
68
Slide 69
69
Slide 70
70
Slide 71
71
Slide 72
72
Slide 73
73
Slide 74
74
Slide 75
75
Slide 76
76
Slide 77
77
Slide 78
78
Slide 79
79
Slide 80
80
Slide 81
81
Slide 82
82
Slide 83
83
Slide 84
84
Slide 85
85
Slide 86
86
Slide 87
87
Slide 88
88
Slide 89
89
Slide 90
90
Slide 91
91
Slide 92
92
Slide 93
93
Slide 94
94
Slide 95
95
Slide 96
96
Slide 97
97
Slide 98
98
Slide 99
99
Slide 100
100
Slide 101
101
Slide 102
102
Slide 103
103
Slide 104
104
Slide 105
105
Slide 106
106
Slide 107
107
Slide 108
108
Slide 109
109
Slide 110
110
Slide 111
111
Slide 112
112
Slide 113
113
Slide 114
114
Slide 115
115
Slide 116
116
Slide 117
117
Slide 118
118
Slide 119
119
Slide 120
120
Slide 121
121
Slide 122
122
Slide 123
123
Slide 124
124
Slide 125
125
Slide 126
126
Slide 127
127
Slide 128
128
Slide 129
129
Slide 130
130
Slide 131
131
Slide 132
132
Slide 133
133
Slide 134
134
Slide 135
135
Slide 136
136
Slide 137
137
Slide 138
138
Slide 139
139
Slide 140
140
Slide 141
141
Slide 142
142
Slide 143
143
Slide 144
144
Slide 145
145

About This Presentation

Classification
Mechanism of action
Duration of action
Absorption and distribution
Mode of action
Theories of action of L.A
Pharmacokinetics of local anaesthetics
Routes of administration
Metabolism or biotransformation
Individual agents
Vasoconstrictors
Systemic effects
Toxicity
Advantages
Disadvant...


Slide Content

PHARMACOLOGY OF LOCAL ANESTHESIA Dr. Ankit Mohapatra , DEPARTMENT OF PUBLIC HEALTH DENTISTRY 1

CONTENTS Definition Introduction Indications Classification Mechanism of action Duration of action Absorption and distribution Mode of action Theories of action of L.A Pharmacokinetics of local anaesthetics Routes of administration 2

Metabolism or biotransformation Individual agents V asoconstrictors Systemic effects Toxicity Causes Factors reducing toxicity Advantages Disadvantages Maximum allowable dose Local anaesthetics in community trust services Conclusion References 3

What is local anesthesia? Local anaesthesia has been defined as loss of sensation in a circumscribed area of the body caused by depression of excitation in nerve endings or inhibition of the conduction process in peripheral nerves. 4

INTRODUCTION Ancient time – dental treatment was associated with pain Earliest pain relief – Coca shrub  mood elevator Incas Cocoa shrub – foot hills of Andes Introduced by  Europeans to South America Cocaine 5

1855 – Gaedicke extracted alkaloid Erythroxylin 1860 – Dr. Scherzer  cocaine from this alkaloid 1844 – Francis Rynd (Dublin)  Acetate of morphine + Creosote Skin incision  TGN(trigeminal neuralgia) treatment First time liquid used - intradermally 1884 – marks birth of LA 6

Sigmund Freud & Carl Koller Cocaine for eye operation William Steward Halsted Cocaine for inferior dental nerve 1886 – Cocaine - dental anesthetic documented by William Alfred Hunt et al 1901 – E Mayers  Vasoconstrictor + cocaine 7

1905 13 lives claimed – addiction A Einhorn & E Uhlfelder (Sweden) Synthesized  Procaine hydrochloride Procaine  sterilizable , non-additive, non-toxic 1943 N Lofgren(Sweden) Synthesized  Anilide called Lignocaine Lignocaine – amide linked synthetic derivative 8

1946 – Lignocaine introduced  Dental practice 1948 – Lignocaine ; published in BDJ – Lofgren Sweden – Birth place of newer LA agents Bupivacaine Ropivacaine 9

INDICATIONS FOR LOCAL ANESTHESIA Most frequent use: regional anesthesia. Analgesic , espescially post operative pain. Lidocaine ( xylocaine ) also reduces blood pressure response to direct laryngoscopic tracheal intubation, an effect probably secondary to generalized cardiovascular depression. Treatment of intractable cough. 10

Local Vs General Anaesthesia General Local Site of action CNS Peripheral nerves Area Whole body Restricted areas Consciousness Lost Unaltered Preferential use Major surgery Minor surgery Use in non-coperative patients Possible Not possible Poor health patient Risky Safer Care for vital functions Essential Not needed 11

CLASSIFICATION OF LOCAL ANESTHESIA 12

CLASSIFICATION ACCORDING TO ROUTE OF ADMINISTRATION Injectable : Low potency, short duration – Procaine and Chlorprocaine Intermediate potency – Lidocaine ( Lignocaine ) and Prilocaine High potency and long duration – Tetracaine , Bupivacaine , Ropivacaine , Etidocaine , Mepivacaine and Dibucaine ( Cinchocaine ) 13

Surface : Soluble – Cocaine, Lidocaine , Tetracaine and Benoxinate Insoluble – Benzocaine , Butylaminobenzoate and Oxethazine Miscellaneous : Clove oil, phenol, chlorpromazine and diphenhydramine etc. 14

CLASSIFICATION ACCORDING TO CHEMISTRY 1. Esters (of benzoic acid) - Butacaine -Cocaine -Benzocaine - Hexylcaine - Piperocaine - Tetracaine 15

2. Esters (of paraaminobenzoic acid) - Chloroprocaine -Procaine - Propoxycaine 16

3. Amides - A rticaine -Bupivacaine - D ibocaine - E tidocaine - L idocaine - M epivacaine - P rilocaine 17

4. Quinoline - Centbucridine 5. Combinations - Lidocaine / Prilocaine ( emla ) 18

6. Natural local anesthetics - Saxitoxin and Tetrodotoxin -Naturally occurring local anesthetics not derived from cocaine are usually neurotoxins, and have the suffix -toxin in their names. -Unlike cocaine produced local anesthetics which are intracellular in effect, - Saxitoxin & Tetrodotoxin bind to the extracellular side of sodium channels. 19

REMEMBER: All LAs are weak Bases! 20

C LAs are Weak Bases C O O R N R R NH O R N R R Aromatic portion Amine portion Intermediate chain ESTER AMIDE LIPOPHILIC (quality of dissolving in lipids) HYDROPHILIC (able to absorb water) 21

MECHANISM - LAs As you know, entry of Na+ is essential for Action potential Two things happen: Rate and rise of AP and depolarization decreases – slowing of conduction. Finally, local depolarization fails to reach threshold potential – conduction block. 22

Mechanism of LAs – contd. LAs interact with a receptor within the voltage sensitive Na+ channel and raise the threshold of opening the channel Na+ permeability decreased and ultimately stopped in response to stimulus or impulse Impulse conduction is interrupted when a critical length of fiber is blocked (2-3 nodes of Ranvier ). 23

Mechanism of LA – contd. Higher concentration of Ca++ reduces inactivation of Na+ channel Blockade is not due to hyperpolarization (RMP is unaltered as K+ channels are not blocked) Blockade is related to pKa (acid dissociation constant) of particular drug: 7.6 to 7.8: e.g. lidocaine - fast acting drugs (more undissociated form) 8.1 to 8.9 : Bupivacine – slow acting (more dissociated form) 24

25

Summary of Mechanism - LAs All local anesthetics are membrane stabilizing drugs slows down speed of AP - ultimately stop AP generation Reversibly decrease the rate of depolarization and repolarization of excitable membranes Act by inhibiting sodium influx through sodium-specific ion channels in the neuronal cell - voltage-gated sodium channels When the influx of sodium is interrupted - action potential cannot rise and signal conduction is inhibited 26

Local anesthetic s bind (located at inner surface) more readily to sodium channels in activated state – and slows its reversion to the resting state – refractory period is increased - “state dependent blockade” - no action on resting nerve. Blockade develops rapidly on stimulation of nerves repeatedly (Greater the stimulation higher is the blockade) Many other drugs also have membrane stabilizing properties, all are not used as LA, e.g. propranolol 27

Fundamentals Of Impulse Generation And Transmission Concept behind action of local anaesthesia- prevent conduction and generation of nerve impulse, set up chemical roadblock between the source of impulse and the brain. NEURON is the fundamental unit of nerve cell. It transmits messages between CNS and all parts of the body. It is of 2 types:- Sensory (afferent) Motor (efferent) 28

Sensory Neuron It transmits pain sensation with 3 major portions:- Peripheral process (dendritic zone) composed of an arborisation of free nerve endings in the most distal segment of sensory neuron. Axon- Thin cable like structure, has free nerve endings that respond to stimulation produced in the tissues in which they lie provoking an impulse transmitted via axon. Cell Body- located at a distance from axon, provide vital metabolic support for the entire neuron. 29

Motor Neuron They transmit nerve impulses from the CNS to the periphery Their cell body is interposed between axon and dendrites. Axon branches with each branch ending as a bulbous axon terminal (or button) Axon terminals synapse with muscle cells. 30

31

Physiology Of Peripheral Nerves The function of nerve is to carry messages from one part of the body to another in the form of electrical action potential called IMPULSES initiated by chemical, mechanical, thermal or electrical stimuli. Action Potential- transient depolarization of membrane which leads to brief increase in permeability of membrane with delayed increase in permeability of potassium. 32

THE ELECTRICAL IMPULSE 33

Nerve impulses are conducted by a wave of action potentials. When a stimulus is great enough to reach the threshold potential of -55mV, sodium ions flow into the neurone. It does so via sodium gates to produce depolarisation.   When depolarised, the membrane potential is reversed to +40 mV. At the same time, there is passive outwards diffusion of potassium ions to bring about repolarisation and the membrane potential is again reversed to -70mV ** mV - milivolt 34

Electrophysiology Of Nerve Conduction Nerve possesses a resting potential which is negative electrical potential of -70mV because of differing in concentration of ions on either side of membrane. Internal to the membrane is negative in respect to the outer part. 35

STEP 1 Stimulation excites the nerve cells. Initial phase of slow depolarization, the electrical potential in the nerve becomes slightly less negative. Falling electrical potential reaches a critical level. Extremely rapid phase of depolarisation result reaches to a threshold potential or firing potential where reversal of electrical potential across nerve membrane occurs. Internal to the membrane becomes positive in respect to the outside (+40mV) 36

37

STEP 2 This is a phase of Repolarisation. Electrical potential gradually becomes more negative in respect to the outside until -70mv is achieved. Step1- 0.3msec Step2- 0.7msec 38

Mechanism of action Inhibiting excitation of nerve endings or blocking conduction in peripheral nerves. Binding to and inactivating sodium channels. Local Anaesthetics are alkaloid bases that are combined with acids, usually hydrochloric, to form water soluble salts. All anaesthetic salts are formed by a combination of weak base and a strong acid. They are stable and soluble in water; water solubility is necessary for their diffusion through interstitial fluids to the nerve fibers. 39

-Sodium influx through these channels is necessary for the depolarization of nerve cell membranes and subsequent propagation of impulses along the course of the nerve. -when a nerve loses depolarization and capacity to propagate an impulse, the individual loses sensation in the area supplied by the nerve 40

block nerve fiber conduction by acting on nerve membranes inhibit sodium ion activity blocks depolarization blocks nerve conduction 41

When the influx of sodium is interrupted, an action potential cannot arise and signal conduction is inhibited. LA drugs bind more readily to sodium channels in activated state, thus onset of neuronal blockade is faster in neurons that are rapidly firing. This is referred to as state dependent blockade. 42

43

Effect of PH Local anesthetics are weak bases and are usually formulated as the hydrochloride salt to render them water-soluble. At the chemical's pKa the protonated (ionized) and unprotonated (unionized) forms of the molecule exist in an equilibrium but only the unprotonated molecule diffuses readily across cell membranes. Once inside the cell the local anesthetic will be in equilibrium, with the formation of the protonated (ionized form), which does not readily pass back out of the cell. This is referred to as "ion-trapping". 44

Effect of PH LA activity increases by increasing PH It is because large amount of a drug is unpolar , it will facilitate its penetration through the cell membrane Once the drug has penetrated the lipid barrier and reach its site of action it is ionized and the ionized form is responsible for LA activity 45

Acidosis caused by inflammation at a wound partly reduces the action of local anesthetics. This is partly because most of the anesthetic is ionized and therefore unable to cross the cell membrane to reach its cytoplasmic -facing site of action on the sodium channel. 46

Local anesthetics blocks conduction in the following order: DIFFERENTIAL BLOCK NB- Pain sensation is blocked more readily than other sensory modalities 47

Small nerve fibres are more sensitive than large nerve fibres Myelinated fibres are blocked before non- myelinated fibres of the same diameter. Thus the loss of nerve function proceeds as loss of pain, temperature, touch, proprioception , and then skeletal muscle tone. This is why people may still feel touch but not pain when using local anaesthesia. 48

Physicochemical characteristics of a local anaesthetic affect its function The aromatic ring structure and hydrocarbon chain length determine the lipid solubility of the drug. The more lipid soluble drug penetrates the cell membrane more easily to exert its effect. Thus bupivacaine – which is highly lipid soluble – Thats the reason it is approximately four times more potent than lidocaine . 49

BINDING OF LOCAL ANESTHETIC TO RECEPTOR 50

The affinity of the receptor site within the sodium channel for the LA is a function of the state of the channel drugs binds to open and inactivated channels, therefore for those with higher activity/firing use dependence - rapidly firing fibers are usually blocked before slowly firing fibers. 51

DURATION OF ACTION The duration of action of the drug is also related to the length of the intermediate chain joining the aromatic and amine groups. Protein binding , Procaine is only 6% protein bound and has a very short duration of action, whereas bupivacaine is 95% protein bound. bupivacaine have a longer duration of action . 52

ABSORPTION AND DISTRIBUTION Some of the drug will be absorbed into the systemic circulation: how much will depend on the vascularity of the area to which the drug has been applied. The distribution of the drug is influenced by the degree of tissue and plasma protein binding of the drug. the more protein bound the agent, the longer the duration of action as free drug is more slowly made available for metabolism.  53

MODE OF ACTION Altering the basic RMP of nerve Altering the threshold potential Decreasing the rate of depolarization Prolonging rate of repolarization 54

THEORIES OF ACTION OF L.A ACTEYLCHOLINE THEORY: Involved in nerve conduction in addition to its role as a neurotransmitter at nerve synapses No such evidence CALCIUM DISPLACEMENT THEORY: L.A causes nerve block by displacement of Ca from some membrane site that controls entry of Na Varying conc. Of Ca in nerve – not seen 55

SURFACE CHARGE THEORY: Action by binding to nerve membrane and changing its electric potential. LA act on nerve channel rather than surface –It cannot explained how uncharged LA molecule causes nerve blockage. 56

Non SPECIFIC MEMBRANE EXPANSION THEORY- LA are lipid soluble – enters nerve membrane and changes configuration of membrane. There by reduced space for sodium to enter and thus cause inhibition. Explains how non ionised drug causes- blockade, nerve membrane do expand and become more fluid when exposed to LA . No evidence to tell that the whole blockade is due to this phenomenon. 57

SPECIFIC RECEPTOR THEORY: The hydrophilic charged amino terminal binds to specific receptors of the sodium gates to block the passage of sodium ions 58

59

SPECIFIC RECEPTOR THEORY — BY F AR THE MOST ACCEPTED THEORY . 60

PHARMACOKINETICS OF LOCAL ANAESTHETICS 61

UPTAKE : When injected into soft tissues, it exerts pharmacologic action on blood vessels in the area. All LA possess a degree of vasoactivity , Most LA produces vasodilation but degree of vasodilation may vary & May produce vasoconstriction. 62

This effects may be concentration dependent. PROCAINE : The most potent vasodilator COCAINE : Only LA which produces vasoconstriction consistently -Initial action : Vasodilation followed by, an intense & prolonged vasoconstriction 63

HOW? By inhibiting uptake of catecholamines into tissue binding sites ( especially norepinephrine ) 64

ROUTES FOR ADMINISTRATION OF LA : 1) ORAL ROUTE 2) TOPICAL ROUTE 3) INJECTION 65

1) ORAL ROUTE All LA are absorbed poorly except cocaine Reason : High first pass metabolism 66

Absorbed at different rates after application to mucous membranes. Whenever no layer of skin is present, topically applied LA can produce an anaesthetic effect. Application to intact skin : no anaesthetic action 2) TOPICAL ROUTE : 67

Topical/Surface anesthesia For Application to mucous membranes:  Nose- Mouth- Esophagus Tracheobronchial tree- Genitourinary tract. Commonly used drugs: Cocaine (4%-10%).  > 50% of rhinolaryngologic cases (USA).  Unique pharmacological property: produces localized vasoconstriction as well as anesthesia.  Localized vasoconstriction: less bleeding. improved surgical field visualization. 68

69

Cocaine substitution:   lidocaine ( Xylocaine ) - oxymetazoline (Afrin) combinations.   tetracaine ( pontocaine )- oxymetazoline (Afrin) combinations. Tetracaine ( pontocaine ) (1%-2%). Lidocaine ( Xylocaine ) (2%-4%). 70

Ineffective agents: Procaine (Novocain) & chloroprocaine ( Nesacaine ): poor mucous membrane penetration. 71

Nebulized lidocaine ( Xylocaine )-- surface anesthesia Upper & lower respiratory tract prior to bronchoscopy or fiber-optic Laryngoscope. Treatment for intractable cough. Normal subjects: No effect on airflow resistance (they produce some bronchodilation ). Patients with asthma: nebulized lidocaine ( Xylocaine ) may increase airflow resistance ( bronchoconstriction )-- concern if bronchoscopy is intended for this patient group. 72

73

Skin Surface Application Barrier: keratinized skin layer Higher local anesthetic concentrations required :  5% lidocaine ( Xylocaine )- prilocaine ( Citanest ) cream {2.5% lidocaine ( Xylocaine ) & 2.5% prilocaine ( Citanest )} no local irritation. even absorption. no systemic toxicity. 74

Combination of local anesthetic: Definition : eutectic mixture of local anesthetics (EMLA) . General definition: eutectic--said of a mixture which has the lowest melting point which it is possible to obtain by the combination of the given components.  Melting point of combined drug is lower then either lidocaine ( Xylocaine ) or prilocaine ( Citanest ) alone. 75

Clinical uses of EMLA applications-- pain relief for: Venipuncture  Lumbar puncture  Arterial cannulation 76

3) INJECTION : Commonly used route for administration of LA Uptake of LA after parentral administration depends on : I. Vascularity of the injection site II. Vasoactivity of the drug 77

Local Infiltration Definition :   Extravascular placement of the local anesthetic in the region to be anesthetized.  Example: subcutaneous local anesthetic injection in support of intravascular cannula placement. Preferred local anesthetics for local infiltration:  Most common: lidocaine ( Xylocaine ).  Other choices: 0.25% Ropivacaine ( Naropin ) or Bupivacaine ( Marcaine ) (effective for pain management at inguinal operative location), 78

Duration of action:   Duration extended by 2x using 1:200,000 epinephrine. Caution: Epinephrine-containing local anesthetic solution should not be injected intracutaneously ( intradermal ) or into tissues supplied by "end-arteries" such as ears, nose, fingers because vasoconstriction may be sufficiently severe to produce tissue ischemia and gangrene. 79

DISTRIBUTION : Once it enters the blood, then distributed to all tissues Brain, head, liver, lungs, kidneys & spleen have high levels of local anaesthetics WHY? Due to their high level of perfusion Skeletal muscle has the highest level because it has the largest mass of tissue in the body 80

THE BLOOD LEVEL OF LOCAL ANAESTHETICS IS INFLUENCED BY Rate at which the drug is absorbed into the CVS Rate of distribution from the vascular compartment to the tissues Elimination of the drug through metabolic or excretory pathways 81

ELIMINATION HALF LIFE : The rate at which a local anaesthetic is removed from the blood, the time necessary for 50% reduction in the blood level. All LAs can cross the blood brain barrier & placenta. 82

METABOLISM OR BIOTRANSFORMATION 83

1) PABA ( Paraaminobenzoic acid) metabolism : - Hydrolyzed in plasma by enzyme pseudo cholinesterase Rate of hydrolysis is related to the degree of toxicity SLOW HYDROLYZATION= INCREASE IN TOXICITY 84

2 ) AMIDE LOCAL ANAESTHETICS : Primary site of metabolism : Liver Prilocaine is metabolized in the liver & lung Rate of metabolism is greatly affected by , Liver function Hepatic perfusion Articaine has a shorter half life than other amides because a portion of its metabolism occurs in the blood by plasma cholinesterase. 85

Metabolism by-products of amide local anaesthetics can possess clinical activity if allowed to accumulate in blood. All local anaesthetics have the ability to cause sedation. 86

EXCRETION : Major excretory organ : Kidneys ESTERS : Almost completely hydrolyzed in plasma, Thus, appear in small concentrations in the urine. In patients undergoing dialysis : They are unable to excrete the unchanged portion of the esters or amides thus increasing toxicity. 87

PROCAINE : Appear in urine as 90% PABA & 2% unchanged. COCAINE : Appear in urine as 10% unchanged. 88

COMPOSITION Local anaesthetic agent : Lidocaine HCL 2% (20 mg/ml Vasoconstrictor: Adrenaline 1:80,000 (0.012 mg) Reducing Agent: Sodium Metabisulphite 0.5 mg - This act's as a preservative for the vasoconstrictor. Preservative: Methylparaben 0.1% (1mg) Isotonic Solution: Sodium Chloride 6 mg 89

Fungicide: Thymol Vehicle: Ringer’s Solution - Minimises discomfort during injection Diluting Agent: Distilled water To adjust pH: Sodium Hydroxide Nitrogen Bubble: 1-2mm in diameter and is present to prevent Oxygen from being trapped in 90

INDIVIDUAL AGENTS 91

Lignocaine Classified under – Amide 2-diethylamino 2,6 acetoxylidide hcl Metabolised - Liver by microsomal fixed function oxidases to monoethyl glycerine and xylidide Excretion -<10% unchanged, >80%- metabolised Vasodilaton ->Procaine, < Mepivacaine 92

NH.CO.CH 2 .N CH 3 CH 3 C 2 H 5 C 2 H 5 LIGNOCAINE 93

Pka –7.9 , ph(plain)-6.5,ph(with Vc )5 –5.5,Onset of action 2-3 min,Anesthetic half life 1.6hrs,topical anesthetic -yes Recommended dose – 7mg/kg not>500mg with VC 4.4mg/kg not>300mg For children with VC 3.2 mg/kg 94

It is non allergic available in three formulations Ligno2% with out Vc Ligno2% with VC 1:80,000 Ligno2% with VC 1:100,000 Adverse reactions - CNS stimulation then Depression,Overdose causes unconsciousness and respiratory arrest. 95

Bupivacaine Classified under amide 1-butyl 2,6 pipecoloxylidide Toxicity <4 times – Lignocaine , Mepivacaine Metabolism –Liver by Amidases Excretion by kidney (16% unchanged) Vasodilation - relatively significant 96

Pka-8.1,ph(plain)- 4.5-6, ph( vc )- 3-4.5 Onset of action –6-10 min, Anesthetic half life-2.7hrs,Dose 1.3mg/kg ,Maximum dose-not >40mg,Absolute maximum dose-not> 90mg 97

N NH.CO C 4 H 9 CH 3 CH 3 BUPIVACAINE 98

Available as 0.5% soln 1:2,00,000 ( vc ) Indicaton - pulpal anesthesia. Full mouth recontruction . Extensive perio surgery. management of post op pain. Duration – Pulpal - 90- 180 min Soft tissue-4-12 hrs Contra indication- burning sensation at site of injecton , in children-anticipating self trauma . 99

Procaine Classified under –Esters 2Diethylamino ethyl 4aminobenzoate hcl Metabolised -in Plasma by plasma pseudocholine esterases Excretion >2%unchanged, 90% -PABA,8% diethyl aminoethanol in urine. Pka-9.1,High degree of vasodilation , 2% procaine 15-30min soft tissue LA 100

No pulpal anesthesia , > incidence of allergy, Drug of choice for intra arterial injection and accidents. 101

Mepivacine Classified -amide type 1 methyl 2,6 pipecoloxylidide hcl Metabolism- microsomal fixed funcn oxidasea in liver. Maximum dose 4.4 mg/kg , absolute max dose-300mg. Excretion-1-10% unchanged urine. Pka-7.6,anesthetic half life-90min, Mild vasodilator, 3% mepivacaine used in patients with vc contraindicaton . Low reported cases-allergy. Over dose CNS stimulation followed by depression. 102

Articaine Classified- amide 2 carboxymethoxy 4 methylthiophene hcl Metabolised - liver Excretion – kidney 10% - unchanged. Pka 7.8, anesthetic half life-1.2-2 hrs, Maximum dose – 1mg/kg , absolute maximum dose –500mg 103

First LA agent with thiophene ring,little potential to diffuse through soft tissue. Adverse reaction- methymoglobinemia - rx by using methylene blue 1mg/kg. 104

Etidocaine Classified –amide Metabolism –liver Excretion –urine- kidney Pka 7.7 ,anesthetic half life-56 min. Maximum dose 8mg /kg, absolute max dose 400 mg Employed mainly in epidural or caudal regional block. 105

VASOCONSTRICTORS Vasoconstrictors are the drugs that constricts the blood vessels and thereby control tissue perfusion. They are added to local anaesthesia to oppose the vasodilatory action of local anesthetic agent. 106

What happens if you don’t use a vasoconstrictor ? * Plain local anesthetics are vasodilators by nature. 1) Blood vessels in the area dilate 2) Increase absorption of the local anesthetic into the cardiovascular system (redistribution) 3) Higher plasma levels  increased risk of toxicity 4) Decreased depth and duration of anesthesia  diffusion from site 5) Increased bleeding due to increased blood perfusion to the area. 107

6) Patient is simply not as numb 7) More anesthetic goes into the circulation 108

Why We Need Vasoconstrictors? 109

Vasoconstrictors resemble adrenergic drugs and are called sympathomimetic , or adrenergic drugs 1) Constrict blood vessels  decrease blood flow to the surgical site 2) Cardiovascular absorption is slowed  lower anesthetic blood levels 110

3) Local anesthetic blood levels are lowered  lower risk of toxicity 4) Local anesthetic remains around the nerve for longer periods  increased duration of anesthesia 5) Decreases bleeding 111

Vasoconstrictors should not be used in the following locations Fingers Toes Nose Ear lobes 112

CLASSIFICATION 113

Catecholamines Non catecholamines Epinephrine Amphetamine Norepinephrine Methamphetamine Levonordefrin Ephedrine Isoproterenol Mephentermine Dopamine Hydroxyamphetamine Metaraminol Methoxamine Phenylephrine 114

SYSTEMIC EFFECTS OF LOCAL ANAESTHETICS 115

CNS In one word : DEPRESSION At high levels, LA will produce tonic- clonic convulsions Procaine, Lidocaine etc produce ANTI- CONVULSANT properties. 116

This drugs are used for management of grand mal & petit mal seizures The depressant action of LA raise the seizure threshold by decreasing the excitability of cortical neurons in epileptic patients 117

PRECONVULSIVE SIGNS & SYMPTOMS Numbness of the tongue & circumoral regions If excitation or sedation occurs in the first 5 or 10 minutes after administration of LA, it should consider as a warning that convulsive activity could be possible. Shivering, slurred speech, muscular twitching, visual/auditory disturbances, dizziness, drowsiness, disorientation & tremor. 118

CONVULSIVE PHASE Duration of seizures is related to blood level of LA & inversely related to arterial pCO2 levels. Seizures last less than or equal to one minute. In seizure, 1) cerebral blood flow & 2) cerebral metabolism increase 119

1 ) CEREBRAL BLOOD FLOW : 120

2 ) CEREBRAL METABOLISM : 121

RESPIRATORY SYSTEM DUAL EFFECTS : Non-overdose levels : Direct relaxant action on bronchial smooth muscle 122

2. Overdose levels : 123

CVS Direct action on myocardium & peripheral vasculature. Increased LA blood levels result in decreased myocardial depolarization Decrease in myocardial excitation, decrease in conduction rate & decrease in the force of contraction Produces hypotension ( direct relaxation effect on vascular smooth muscle ) 124

LOCAL TISSUE TOXICITY Skeletal muscle will heal within 2 weeks of being injected with local anaesthetic. Longer acting LA produces more damage to skeletal muscle than shorter acting LA. 125

TOXICITY OF LOCAL ANAESTHESIA 1- Causes 2- Factors reducing toxicity. 126

CAUSES Accidental rapid intravenous injection . Rapid absorption, such as from a very vascular site ie mucous membranes. Overdose . 127

FACTORS REDUCING TOXICITY Decide on the concentration of the local anaesthetic that is required for the block to be performed. Calculation of the total volume of drug should be done. Use the least toxic drug available . Use lower doses in frail patients or at the extremes of ages. Always inject the drug slowly (around 1ml /minute) and aspirate regularly looking for blood to indicate an accidental intravenous injection 128

If Injection of a test dose of 2-3ml of local anaesthetic containing adrenaline is accidentally given intravenously it will often (but not always) cause significant tachycardia . Add adrenaline (epinephrine) to reduce the speed of absorption. The addition of adrenaline will reduce the maximum blood concentration by about 50%. Usually adrenaline is added in a concentration of 1:200,000, with a maximum dose of 200 micrograms. 129

Make sure that the patient is monitored closely by the anaesthetist or a trained nurse during the administration of the local anaesthetic and following the surgery. 130

ADVANTAGES OF LOCAL ANAESTHESIA During local anesthesia the patient remains conscious Maintains his own airway. Excellent muscle relaxant effect. requires less skilled nursing care as compared to other anesthesia like general anesthesia. Non inflammable. 131

Less pulmonary complications Aspiration of gastric contents unlikely. Less nausea and vomiting. Contracted bowel so helpful in abdominal and pelvic surgery. Postoperative  analgesia. There is reduction surgical stress. Earlier discharge for outpatients. 132

Suitable for patients who recently ingested food or fluids. Local anesthesia is useful for ambulatory patients having minor procedures. Ideal for procedures in which it is desirable to have the patient awake and cooperative. Less bleeding. Expenses are less. 133

DISADVANTAGES OF LOCAL ANAESTHESIA There are individual variations in response to local anesthetic drugs. Rapid absorption of the drug into the bloodstream can cause severe, potentially fatal reactions. Apprehension may be increased by the patient's ability to see and hear. Some patients prefer to be unconscious and unaware. 134

Direct damage of nerve. Post- dural headache from CSF leak. Hypotension and bradycardia through blockade of the sympathetic nervous system. Not suitable for extremes of ages. Multiple needle pricks may be needed. 135

MAXIMUM ALLOWABLE DOSE 136

137

138

LOCAL ANAESTHETICS IN COMMUNITY TRUST SERVICES Dentists can legally write prescriptions for medication and administer LAs within their scope of practice and at community outreach programmes. 139

The following local anaesthetics are prescribed for use within the community dental services for local injection in dental procedures: Articaine 4% with Adrenaline [epinephrine] (1 in 100,000) Cartridges Mepivacaine 3% Cartridges Lidocaine 2% with Adrenaline [epinephrine] (1 in 80, 000) Cartridges Prilocaine 3% with Octapressin Cartridges 140

CONCLUSION 141 Local anesthesia has been the cornerstone of modern day pain-free dental practice. However, the practitioners limitations in updating about newer drug formulations available and newer techniques to administer the drugs has, still not made the goal of pain-free dentistry a reality.

The availability and cost factors are not excuses not to adapt newer proven methods, when the benefits outweigh the shortcomings. There is a need in the current evidence-based era of dental practice for us to constantly update, evaluate and incorporate newer drugs and techniques into daily practice to provide our patients the best of care at all times. 142

A clinician s ability to administer an effective, safe and atraumatic local anesthesia injection to a child (or adult) is a major factor in creating a patient with a life long acceptance of dental treatment.  Rather than avoiding local administration for fear of traumatizing the pediatric patient, the clinician should strive to learn and use the latest modalities of local pain control to create a pleasant and comfortable dental experience for the patient. Steven Schwartz, DDS. Continuing Dental Education . OHIO, USA: Local Anesthesia in Pediatric Dentistry. 05 June 2016. http://www.dentalcare.com/en-US/dental-education/continuing-education/ce325/ce325.aspx?ModuleName=coursecontent&PartID=10&SectionID=-1 143

REFERENCES K.D. TRIPATHI text book of pharmacology. Pharmacology an introductory text: Mary Kaye Asperheim , 6 th edn . Text book of pharmacology, 1 st edn , H.L. Sharma. . Text book of Peridontology : Carranza. Malamed , Stanley F.  Handbook of local anesthesia . 5 TH edition. Elsevier Health Sciences, 2014. Handbook of Local Anesthesia . Br.J.Anaesth. (2013) 110 (4):666-667. Local Anesthesia of the Oral Cavity: Jastak JT .W.B. Saunders Co.; 1995. 1st ed. 144

145